{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:14:36Z","timestamp":1788498876039,"version":"build-2803163510"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40290-026-00626-w","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:14:34Z","timestamp":1787048074000},"page":"373-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication Safety in India and Southeast Asia: A SWOT Analysis of Policies and Practices"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7411-5335","authenticated-orcid":false,"given":"Sangeeta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminder","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra Nath","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kotwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"626_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2471\/BLT.17.198002","volume":"95","author":"A Sheikh","year":"2017","unstructured":"Sheikh A, Dhingra-Kumar N, Kelley E, Kieny MP, Donaldson LJ. The third global patient safety challenge: tackling medication-related harm. Bull World Health Organ. 2017;95:546\u201356.","journal-title":"Bull World Health Organ"},{"key":"626_CR2","unstructured":"World Health Organization. Patient safety fact sheet. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/patient-safety. Accessed 8 June 2026."},{"key":"626_CR3","unstructured":"World Health Organization. Medication without harm: global patient safety challenge on medication safety. 2017. https:\/\/www.who.int\/initiatives\/medication-without-harm. Accessed 8 June 2026."},{"key":"626_CR4","first-page":"23","volume":"153","author":"P Carayon","year":"2010","unstructured":"Carayon P, Wood KE. Patient safety: the role of human factors and systems engineering. Stud Health Technol Inform. 2010;153:23\u201346.","journal-title":"Stud Health Technol Inform."},{"key":"626_CR5","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3390\/ijerph17062028","volume":"17","author":"M Vaismoradi","year":"2020","unstructured":"Vaismoradi M, Tella S, Logan PA, Khakurel J, Vizcaya-Moreno F. Nurses\u2019 adherence to patient safety principles: a systematic review. Int J Environ Res Public Health. 2020;17:2028.","journal-title":"Int J Environ Res Public Health"},{"key":"626_CR6","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1097\/CCM.0000000000002533","volume":"45","author":"SL Kane-Gill","year":"2017","unstructured":"Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, Liu M, Cohen H, et al. Clinical practice guideline: safe medication use in the ICU. Crit Care Med. 2017;45:e877-915.","journal-title":"Crit Care Med"},{"key":"626_CR7","first-page":"2523","volume":"9","author":"T Katariya","year":"2020","unstructured":"Katariya T, Gambhire MS, Gambhire VM. A review of current regulatory requirements for drug approval submissions in ASEAN countries. World J Pharm Pharm Sci. 2020;9:2523\u201331.","journal-title":"World J Pharm Pharm Sci."},{"key":"626_CR8","unstructured":"ASEAN-Japan Centre. Assessing digital health adoption in ASEAN. 2024. https:\/\/www.asean.or.jp\/main-site\/wp-content\/uploads\/2024\/07\/Assessing-Digital-Health-Adoption-in-ASEAN.pdf. Accessed 9 June 2026."},{"key":"626_CR9","unstructured":"Hui Sin T. Medicines regulatory systems and scope for regulatory harmonization in Southeast Asia. https:\/\/documents.worldbank.org\/curated\/en\/727671496171008743\/Medicines-regulatory-systems-and-scope-for-regulatory-harmonization-in-Southeast-Asia. Accessed 9 June 2026."},{"key":"626_CR10","doi-asserted-by":"publisher","DOI":"10.1787\/aad87f86-en","volume-title":"Supporting regulatory reforms in Southeast Asia","author":"OECD","year":"2022","unstructured":"OECD. Supporting regulatory reforms in Southeast Asia. Paris: OECD Publishing; 2022. https:\/\/doi.org\/10.1787\/aad87f86-en."},{"issue":"9","key":"626_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136545","volume":"10","author":"S Salmasi","year":"2015","unstructured":"Salmasi S, Khan TM, Hong YH, Ming LC, Wong TW. Medication errors in the Southeast Asian countries: a systematic review. PLoS ONE. 2015;10(9):e0136545. https:\/\/doi.org\/10.1371\/journal.pone.0136545.","journal-title":"PLoS ONE"},{"key":"626_CR12","doi-asserted-by":"publisher","first-page":"e1196","DOI":"10.1016\/S2214-109X(18)30386-3","volume":"6","author":"M Kruk","year":"2018","unstructured":"Kruk M, Gage A, Arsenault C, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet Glob Health. 2018;6:e1196\u2013252.","journal-title":"Lancet Glob Health"},{"key":"626_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100306","volume":"18","author":"B Sihombing","year":"2023","unstructured":"Sihombing B, Bhatia R, Srivastava R, Aditama TY, Laxminarayan R, Rijal S. Response to antimicrobial resistance in South-East Asia Region. Lancet Reg Health Southeast Asia. 2023;18:100306. https:\/\/doi.org\/10.1016\/j.lansea.2023.100306.","journal-title":"Lancet Reg Health Southeast Asia."},{"issue":"3","key":"626_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29060\/TAPS.2024-9-3\/OA3045","volume":"9","author":"DD Samarasekera","year":"2024","unstructured":"Samarasekera DD, Lee SS, Yeo SP, Chen J, Findyartini A, Greviana N, et al. The state of continuing professional development in East and Southeast Asia among medical practitioners. Asia Pac Scholar. 2024;9(3):1\u201314. https:\/\/doi.org\/10.29060\/TAPS.2024-9-3\/OA3045.","journal-title":"Asia Pac Scholar."},{"issue":"3","key":"626_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bja.2024.06.006","volume":"133","author":"CS Webster","year":"2024","unstructured":"Webster CS. Safety improvement requires data: the case for automation and artificial intelligence during incident reporting. Br J Anaesth. 2024;133(3):491\u20133. https:\/\/doi.org\/10.1016\/j.bja.2024.06.006.","journal-title":"Br J Anaesth"},{"key":"626_CR16","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1186\/s12913-021-07187-5","volume":"21","author":"A Afaya","year":"2021","unstructured":"Afaya A, Konlan KD, Do KH. Improving patient safety through identifying barriers to reporting medication administration errors among nurses: an integrative review. BMC Health Serv Res. 2021;21:1156. https:\/\/doi.org\/10.1186\/s12913-021-07187-5.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"626_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/2042098616665290","volume":"7","author":"S Sharma","year":"2024","unstructured":"Sharma S, Tabassum F, Khurana S, Kapoor K. Frontline worker perceptions of medication safety in India. Ther Adv Drug Saf. 2024;7(6):248\u201360. https:\/\/doi.org\/10.1177\/2042098616665290.","journal-title":"Ther Adv Drug Saf"},{"key":"626_CR18","unstructured":"ASEAN. Guidelines for implementation of harmonised accreditation in ASEAN. 2022. https:\/\/asean.org\/wp-content\/uploads\/2022\/11\/Guidelines-for-Implementation-of-Harmonised-Accreditation-in-ASEAN-ebook-28102022.pdf. Accessed 9 June 2026."},{"key":"626_CR19","unstructured":"Ministry of Health & Family Welfare, Government of India. National patient safety implementation framework (2018\u20132025). https:\/\/main.mohfw.gov.in\/sites\/default\/files\/national%20patient%20safety%20implimentation_for%20web.pdf. Accessed 8 June 2026."},{"key":"626_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0972266120929146","volume":"25","author":"V Motkuri","year":"2020","unstructured":"Motkuri V, Mishra RN. Pharmaceutical market and drug price policy in India. Rev Dev Change. 2020;25:30\u201353. https:\/\/doi.org\/10.1177\/0972266120929146.","journal-title":"Rev Dev Change"},{"key":"626_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jgs.14683","volume":"65","author":"N Ferrah","year":"2016","unstructured":"Ferrah N, Lovell JJ, Ibrahim JE. Systematic review of the prevalence of medication errors resulting in hospitalization and death of nursing home residents. J Am Geriatr Soc. 2016;65:433\u201342.","journal-title":"J Am Geriatr Soc"},{"key":"626_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.12968\/bjon.2017.26.3.159","volume":"26","author":"C Kavanagh","year":"2017","unstructured":"Kavanagh C. Medication governance: preventing errors and promoting patient safety. Br J Nurs. 2017;26:159\u201365.","journal-title":"Br J Nurs"},{"key":"626_CR23","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/j.1475-6773.2012.01390.x","volume":"47","author":"R Lawton","year":"2012","unstructured":"Lawton R, Carruthers S, Gardner P, Wright J, McEachan RC. Identifying the latent failures underpinning medication administration errors: an exploratory study. Health Serv Res. 2012;47:1437\u201359.","journal-title":"Health Serv Res"},{"issue":"Suppl. 3","key":"626_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003755","volume":"6","author":"J Kootstra","year":"2021","unstructured":"Kootstra J, Kleinhout VT. Implementing pharmaceutical track and trace systems: a realist review. BMJ Glob Health. 2021;6(Suppl. 3):e003755.","journal-title":"BMJ Glob Health"},{"key":"626_CR25","doi-asserted-by":"crossref","unstructured":"Kulkarni SR, Purswani D. Implementation of track and trace systems at pharmaceuticals industry. J Inf Syst Eng Manag. 2025;10(19s).","DOI":"10.52783\/jisem.v10i19s.3120"},{"key":"626_CR26","unstructured":"Indian Pharmacopoeia Commission. ADR monitoring centers & enrolment form for new AMC: Pharmacovigilance Programme of India (PvPI). Updated May 13, 2026. https:\/\/ipc.gov.in\/mandates\/pvpi\/adr-monitoring-centers.html. Accessed 9 June 2026."},{"key":"626_CR27","unstructured":"Ministry of Health and Family Welfare, Government of India. Drugs (Amendment) Rules, 2023: Notification G.S.R. 922(E), dated December 28, 2023 (Revised Schedule M -Good Manufacturing Practices). https:\/\/pharmadocx.com\/wp-content\/uploads\/2024\/01\/Notified-Schedule-M-dt-28.12.2023-1.pdf. Accessed 9 June 2026."},{"issue":"3","key":"626_CR28","first-page":"1","volume":"8","author":"E Tomas","year":"2024","unstructured":"Tomas E. Pharmacovigilance and post marketing surveillance: ensuring drug safety after approval. J Pharmacovigil. 2024;8(3):1\u20135.","journal-title":"J Pharmacovigil"},{"key":"626_CR29","unstructured":"World Health Organization, Regional Office for South-East Asia. WHO South-East Asia regional roadmap for results and resilience (ROADMAP). 2024. https:\/\/iris.who.int\/handle\/10665\/376835. Accessed 8 June 2026."},{"key":"626_CR30","unstructured":"Ministry of Chemicals & Fertilizers, Government of India. Department of Pharmaceuticals. Annual report 2020\u201321. https:\/\/pharma-dept.gov.in\/sites\/default\/files\/english%20Annual%20Report%202020-21_0.pdf. Accessed 9 June 2026."},{"issue":"5","key":"626_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/14787210.2022.2015324","volume":"20","author":"P Anand","year":"2022","unstructured":"Anand P, Kaur N, Verma V, Shafiq N, Malhotra S. Assessment of rationality of available fixed dose combinations of antibiotics in India. Expert Rev Anti Infect Ther. 2022;20(5):797\u2013808. https:\/\/doi.org\/10.1080\/14787210.2022.2015324.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"626_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-022-00428-w","volume":"15","author":"G Sulis","year":"2022","unstructured":"Sulis G, Pradhan R, Kotwani A, Gandra S. India\u2019s ban on antimicrobial fixed-dose combinations: winning the battle, losing the war? J Pharm Policy Pract. 2022;15(1):33. https:\/\/doi.org\/10.1186\/s40545-022-00428-w.","journal-title":"J Pharm Policy Pract"},{"key":"626_CR33","unstructured":"Central Drugs Standard Control Organization. System of preliminary scrutiny for approval of fixed dose combinations (FDCs). 2014. https:\/\/cdsco.gov.in\/opencms\/opencms\/en\/Drugs\/FDC\/. Accessed 1 Feb 2025."},{"key":"626_CR34","unstructured":"World Health Organization. Substandard and falsified medical products. December 3, 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products. Accessed 8 June 2026."},{"key":"626_CR35","unstructured":"OHCHR. Bridging the global gap in access to essential medicines. https:\/\/www.ohchr.org\/en\/stories\/2025\/07\/bridging-global-gap-access-essential-medicines. Accessed 9 June 2026."},{"issue":"5","key":"626_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5281\/zenodo.15345689","volume":"2","author":"A Kumar","year":"2025","unstructured":"Kumar A, Srivastava AK, Ansari F, Kumar K, Vishwakarma M, Shekhar S, et al. Disparities in access to essential medicines in India: a systematic review. Int J Sci Res Technol. 2025;2(5):147\u201360. https:\/\/doi.org\/10.5281\/zenodo.15345689.","journal-title":"Int J Sci Res Technol."},{"issue":"2","key":"626_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/heapol\/czi015","volume":"20","author":"RR Chaudhury","year":"2005","unstructured":"Chaudhury RR, Parameswar R, Gupta U, Sharma S, Tekur U, Bapna JS. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs. Health Policy Plan. 2005;20(2):124\u201336.","journal-title":"Health Policy Plan"},{"issue":"5","key":"626_CR38","first-page":"645","volume":"125","author":"A Kotwani","year":"2007","unstructured":"Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, et al. Prices and availability of common medicines at six sites in India. Indian J Med Res. 2007;125(5):645\u201354.","journal-title":"Indian J Med Res"},{"key":"626_CR39","first-page":"1013","volume":"10","author":"AGR Saravanan","year":"2023","unstructured":"Saravanan AGR, Jagadeesan M. Irrational fixed-dose combinations in clinical practice. SCOPE J. 2023;10:1013\u201325.","journal-title":"SCOPE J."},{"key":"626_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13756-023-01238-8","volume":"12","author":"K Vliegenthart-Jongbloed","year":"2023","unstructured":"Vliegenthart-Jongbloed K, Jacobs J. Not recommended fixed-dose antibiotic combinations in low- and middle-income countries. Antimicrob Resist Infect Control. 2023;12:37. https:\/\/doi.org\/10.1186\/s13756-023-01238-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"7","key":"626_CR41","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1111\/bcp.14711","volume":"87","author":"B Sayer","year":"2021","unstructured":"Sayer B, Bortone B, Sharland M, Hsia Y. Fixed-dose combination antibiotics: the search for evidence using ampicillin-cloxacillin. Br J Clin Pharmacol. 2021;87(7):2996\u20139. https:\/\/doi.org\/10.1111\/bcp.14711.","journal-title":"Br J Clin Pharmacol"},{"key":"626_CR42","unstructured":"Padmane SP, Newargade SA. A review on fixed dose combinations: irrational drug combinations and patient compliance. IJEDR. 2019;7(3)."},{"issue":"6","key":"626_CR43","doi-asserted-by":"publisher","first-page":"E472","DOI":"10.1001\/amajethics.2024.472","volume":"26","author":"AB Cadwallader","year":"2024","unstructured":"Cadwallader AB, Nallathambi K. Why assuring the quality of antimicrobials is a global imperative. AMA J Ethics. 2024;26(6):E472\u20138. https:\/\/doi.org\/10.1001\/amajethics.2024.472.","journal-title":"AMA J Ethics"},{"key":"626_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-017078","volume":"10","author":"EM Maffioli","year":"2025","unstructured":"Maffioli EM, Lu Y, Anyakora C. Substandard and falsified antibiotics and antimicrobial resistance: a retrospective analysis. BMJ Glob Health. 2025;10:e017078. https:\/\/doi.org\/10.1136\/bmjgh-2024-017078.","journal-title":"BMJ Glob Health"},{"key":"626_CR45","unstructured":"National Health Mission. Free drugs and diagnostics service initiative guidelines. Government of India. https:\/\/nhsrcindia.org\/sites\/default\/files\/2021-05\/Free-Diagnostics-Service-Initiative.pdf. Accessed 10 June 2026."},{"key":"626_CR46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/s12913-022-08022-1","volume":"22","author":"S Lavtepatil","year":"2022","unstructured":"Lavtepatil S, Ghosh S. Improving access to medicines by popularising generics: a study of Jan Aushadhi scheme. BMC Health Serv Res. 2022;22:643. https:\/\/doi.org\/10.1186\/s12913-022-08022-1.","journal-title":"BMC Health Serv Res"},{"key":"626_CR47","unstructured":"Ministry of Health & Family Welfare, Government of India. Ayushman Arogya Mandir report card. https:\/\/aam.mohfw.gov.in\/. Accessed 10 June 2026."},{"key":"626_CR48","unstructured":"Department of Pharmaceuticals, Government of India. Annual report 2025\u20132026. https:\/\/janaushadhi.gov.in:10443\/jasprodobt\/Reports\/f59d96cf74e18cf6.pdf. Accessed 10 June 2026."},{"key":"626_CR49","unstructured":"Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). Department of Pharmaceuticals. https:\/\/static.pib.gov.in\/WriteReadData\/specificdocs\/documents\/2025\/jan\/doc202516481901.pdf. Accessed 10 June 2026."},{"key":"626_CR50","unstructured":"Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). Advancing affordable and equitable healthcare. https:\/\/static.pib.gov.in\/WriteReadData\/specificdocs\/documents\/2026\/mar\/doc202637814101.pdf Accessed 18 June 2026."},{"key":"626_CR51","unstructured":"Kumar AP, Divyashree M, Shetty M, Renuka V, Gowda S, Yashaswini. Regulatory requirements of over-the-counter (OTC) drugs in India as per CDSCO in comparison with the United States of America. Eur J Pharm Med Res. 2024;11(10):561\u201370."},{"issue":"1","key":"626_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/jpgm.JPGM_381_19","volume":"66","author":"PA Marathe","year":"2020","unstructured":"Marathe PA, Kamat SK, Tripathi RK, Raut SB, Khatri NP. Over-the-counter medicines: global perspective and Indian scenario. J Postgrad Med. 2020;66(1):28\u201334. https:\/\/doi.org\/10.4103\/jpgm.JPGM_381_19.","journal-title":"J Postgrad Med"},{"key":"626_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s44250-023-00032-y","volume":"2","author":"P Narang","year":"2023","unstructured":"Narang P, Garg V, Sharma A. Regulatory, safety and economic considerations of over-the-counter medicines in the Indian population. Discov Health Syst. 2023;2:17. https:\/\/doi.org\/10.1007\/s44250-023-00032-y.","journal-title":"Discov Health Syst"},{"key":"626_CR54","unstructured":"Rajput TA, Shinde I. Over the counter (OTC) medications: safety, accessibility, and regulatory considerations. Indo Am J Pharm Res. 2024. https:\/\/www.iajpr.com\/. Accessed 10 June 2026."},{"key":"626_CR55","unstructured":"World Health Organization. Global burden of preventable medication-related harm in health care: a systematic review. March 7, 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240088887. Accessed 10 June 2026."},{"key":"626_CR56","unstructured":"ASEAN. ASEAN pharmaceutical regulatory framework. 2022. https:\/\/asean.org\/wp-content\/uploads\/2023\/11\/Final-Clean-Text-APRFAdopted-AHMM-AEM-5-Apr.pdf. Accessed 14 June 2026."},{"key":"626_CR57","unstructured":"ASEAN. Measuring progress of the ASEAN strategic framework to combat antimicrobial resistance through one health approach (ASF-AMR): monitoring and evaluation report 2023. November 2024. https:\/\/asean.org\/wp-content\/uploads\/2025\/06\/Measuring-Progress-of-the-ASF-AMR_Report-on-2023-Data_Final.pdf. Accessed 14 June 2026."},{"key":"626_CR58","unstructured":"World Health Organization. Regional strategic roadmap on health security and health system resilience for emergencies 2023\u20132027. July 2022. https:\/\/www.who.int\/publications\/i\/item\/9789290209959. Accessed 12 June 2026."},{"key":"626_CR59","unstructured":"Hoffman M, Anderson S. WHO delays falsified medicine mechanism reform amid health crisis. Health Policy Watch. May 27, 2025. https:\/\/healthpolicy-watch.news\/who-delays-falsified-medicine-mechanism-reform-amid-health-crisis\/. Accessed 12 June 2026."},{"issue":"1","key":"626_CR60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.55642\/phasij.v5i01.1116","volume":"5","author":"A Nursyabila","year":"2025","unstructured":"Nursyabila A, Jamal SA, Haviana E, Hardi Y. Global perspectives on pharmaceutical tracking and traceability systems: a review of logistics technologies in healthcare. Public Health Saf Int J. 2025;5(1):341\u20138. https:\/\/doi.org\/10.55642\/phasij.v5i01.1116.","journal-title":"Public Health Saf Int J."},{"key":"626_CR61","unstructured":"European Medicines Agency. ICMRA: mapping of supply chain\/anticounterfeiting initiatives. 2016. https:\/\/www.ema.europa.eu\/en\/documents\/other\/icmra-mapping-supply-chainanticounterfeiting-initiatives_en.pdf. Accessed 13 June 2026."},{"key":"626_CR62","unstructured":"National Agency for Food and Drug Administration and Control (NAFDAC). Drug and food regulation: international collaboration on counterfeit drug prevention. February 2, 2025. https:\/\/nafdac.org\/drugs-counterfeit-drug-prevention-international-collaboration. Accessed 13 June 2026."},{"key":"626_CR63","unstructured":"International Alliance of Patients\u2019 Organizations (IAPO). Counterfeit medicines. 2024. https:\/\/www.iapo.org.uk\/counterfeit-medicines. Accessed June 2026."},{"key":"626_CR64","volume-title":"The WHO Member State mechanism on substandard and falsified medical products","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. The WHO Member State mechanism on substandard and falsified medical products. Geneva: World Health Organization; 2023."},{"key":"626_CR65","unstructured":"World Health Organization. Antimicrobial resistance fact sheet. November 21, 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Accessed 13 June 2026."},{"key":"626_CR66","doi-asserted-by":"crossref","unstructured":"Alomari R, Abdel-Razeq A, Shamiah H. Comprehensive assessment of the global burden of antimicrobial resistance: trends and insights from 2000 to 2023. Am J Biomed 2024;12(4):151\u201368. https:\/\/ajbm.net\/research-article_122632html\/. Accessed 13 June 2026.","DOI":"10.18081\/2333-5106\/2024.12\/151"},{"key":"626_CR67","doi-asserted-by":"publisher","unstructured":"Otaigbe II, Elikwu. Drivers of inappropriate antibiotic use in low- and middle-income countries. JAC Antimicrob Resist. 2023;5(3):dlad062. https:\/\/doi.org\/10.1093\/jacamr\/dlad062.","DOI":"10.1093\/jacamr\/dlad062"},{"key":"626_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006290","volume":"5","author":"F El-Jardali","year":"2015","unstructured":"El-Jardali F, Akl EA, Fadlallah R, et al. Interventions to combat or prevent drug counterfeiting: a systematic review. BMJ Open. 2015;5:e006290. https:\/\/doi.org\/10.1136\/bmjopen-2014-006290.","journal-title":"BMJ Open"},{"key":"626_CR69","unstructured":"World Health Organization. Regional roadmap to accelerate actions on antimicrobial resistance in the human health sector in the South-East Asia Region (2025\u20132030). https:\/\/www.who.int\/publications\/i\/item\/9789290221159. Accessed 14 June 2026."},{"key":"626_CR70","unstructured":"Institute for Safe Medication Practices. More can be done to alleviate errors associated with pharmaceutical product labeling and packaging. 2021. https:\/\/www.ismp.org\/resources\/more-can-be-done-alleviate-errors-associated-pharmaceutical-product-labeling-and#:~:text=ISMP%20also%20recommends%20that%20ALL,practicing%20healthcare%20clinicians%20as%20needed. Accessed 14 June 2026."},{"issue":"4","key":"626_CR71","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.5530\/ijper.58.4.116","volume":"58","author":"GK Ravindra","year":"2024","unstructured":"Ravindra GK, Subramaniam B, Veeranna B. Standards of child resistant packaging: a regulatory view. Indian J Pharm Educ Res. 2024;58(4):1045\u201353.","journal-title":"Indian J Pharm Educ Res."},{"key":"626_CR72","doi-asserted-by":"publisher","unstructured":"Al-Worafi YM. Quality of healthcare systems in developing countries: status and future recommendations. In: Al-Worafi YM, editor. Handbook of medical and health sciences in developing countries. Cham: Springer; 2026. https:\/\/doi.org\/10.1007\/978-3-030-74786-2.","DOI":"10.1007\/978-3-030-74786-2"},{"key":"626_CR73","unstructured":"Ministry of Health and Family Welfare, Government of India. Drugs (Eighth Amendment) Rules, 2022 (G.S.R. 823(E), November 17, 2022). Amendment to Drugs Rules, 1945 introducing Schedule H2 and mandating bar code\/QR code on drug labels. Government of India (Department of Publication, Ministry of Housing and Urban Affairs, publisher of The Gazette of India); 2022."},{"key":"626_CR74","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40264-013-0090-2","volume":"36","author":"RN Keers","year":"2013","unstructured":"Keers RN, Williams SD, Cooke J, Ashcroft DM. Causes of medication administration errors in hospitals: a systematic review. Drug Saf. 2013;36:1045\u201367. https:\/\/doi.org\/10.1007\/s40264-013-0090-2.","journal-title":"Drug Saf"},{"issue":"4","key":"626_CR75","first-page":"199","volume":"37","author":"M Grissinger","year":"2012","unstructured":"Grissinger M. Color-coded syringes for anesthesia drugs: use with care. P T. 2012;37(4):199\u2013201.","journal-title":"P T"},{"key":"626_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050210","volume":"5","author":"A Fugh-Berman","year":"2008","unstructured":"Fugh-Berman A, Melnick D. Off-label promotion, on-target sales. PLoS Med. 2008;5:e210.","journal-title":"PLoS Med"},{"issue":"3","key":"626_CR77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/2229-3485.159935","volume":"6","author":"SS Oberoi","year":"2015","unstructured":"Oberoi SS. Regulating off-label drug use in India: the arena for concern. Perspect Clin Res. 2015;6(3):129\u201333. https:\/\/doi.org\/10.4103\/2229-3485.159935.","journal-title":"Perspect Clin Res"},{"key":"626_CR78","first-page":"974","volume":"32","author":"G Mudur","year":"2004","unstructured":"Mudur G. Indian medical association wants off-label prescribing. BMJ. 2004;32:974.","journal-title":"BMJ"},{"issue":"5","key":"626_CR79","doi-asserted-by":"publisher","first-page":"329","DOI":"10.31128\/AJGP-08-20-5591","volume":"50","author":"JS Bell","year":"2021","unstructured":"Bell JS, Richards GC. Off-label medicine use: ethics, practice, and future directions. Aust J Gen Pract. 2021;50(5):329\u201331. https:\/\/doi.org\/10.31128\/AJGP-08-20-5591.","journal-title":"Aust J Gen Pract"},{"key":"626_CR80","unstructured":"European Patients\u2019 Academy (EUPATI). Off-label use of medicines. https:\/\/learning.eupati.eu\/mod\/book\/view.php?id=913&chapterid=896. Accessed 15 June 2026."},{"issue":"6","key":"626_CR81","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.5281\/zenodo.20552346","volume":"4","author":"A Kumar","year":"2026","unstructured":"Kumar A, Hussain K. Evolving regulatory framework for e-pharmacies in India: challenges and legal concerns. Int J Pharm Sci. 2026;4(6):1264\u201377. https:\/\/doi.org\/10.5281\/zenodo.20552346.","journal-title":"Int J Pharm Sci"},{"key":"626_CR82","unstructured":"Krishanga. E-pharmacy: why is India still waiting to legalize its regulation? MedIndia 2023. https:\/\/www.medindia.net\/news\/healthwatch\/e-pharmacy-why-is-india-still-waiting-to-legalize-its-regulation-213293-1.htm. Accessed 13 June 2026."},{"key":"626_CR83","unstructured":"Navigating the future of e-pharmacies: balancing accessibility and regulation in India. Lexology 2025. https:\/\/www.lexology.com\/library\/detail.aspx?g=59a048e6-dc1f-4f39-a0f7-ebb3e94a4abb. Accessed 12 June 2026."},{"key":"626_CR84","unstructured":"Jha S. Unregulated growth: the perilous gaps in India\u2019s booming e-pharmacy sector. The South First 2025. https:\/\/thesouthfirst.com\/health\/unregulated-growth-the-perilous-gaps-in-indias-booming-e-pharmacy-sector\/. Accessed 12 June 2026."},{"key":"626_CR85","volume-title":"Strengthening pharmaceutical regulatory systems and regional collaboration in South-East Asia","author":"World Health Organization South-East Asia Regulatory Network","year":"2023","unstructured":"World Health Organization South-East Asia Regulatory Network. Strengthening pharmaceutical regulatory systems and regional collaboration in South-East Asia. New Delhi: WHO SEARO; 2023."},{"key":"626_CR86","unstructured":"ASEAN. Terms of reference of the Pharmaceutical Product Working Group (PPWG). https:\/\/www.tisi.go.th\/data\/interstandard\/pdf\/asean\/asean_ppwg_tor_2_6.pdf. Accessed 12 June 2026."},{"issue":"1","key":"626_CR87","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12913-025-12449-7","volume":"25","author":"M Mahdavi","year":"2025","unstructured":"Mahdavi M, et al. Telemedicine and patient safety: a scoping review. BMC Health Serv Res. 2025;25(1):112.","journal-title":"BMC Health Serv Res"},{"key":"626_CR88","unstructured":"Nguyen DD. Building inclusive and collaborative digital health development in Southeast Asia: a comparative analysis of Vietnam and Indonesia. Konrad-Adenauer-Stiftung; 2024. https:\/\/www.kas.de\/documents\/d\/politikdialog-asien\/panorama_2024-1-71-92. Accessed 12 June 2026."},{"key":"626_CR89","unstructured":"World Health Organization. Digital health in the South-East Asia Region. https:\/\/www.who.int\/southeastasia\/health-topics\/digital-health. Accessed 10 June 2026."},{"key":"626_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/frhs.2025.1654514","volume":"5","author":"D Kanyal","year":"2025","unstructured":"Kanyal D, Ghewade B. Evaluating quality improvement in tertiary care hospital before and after NABH accreditation: a systematic review. Front Health Serv. 2025;5:1654514. https:\/\/doi.org\/10.3389\/frhs.2025.1654514.","journal-title":"Front Health Serv"},{"key":"626_CR91","unstructured":"Golandaj JA, Kallihal KG. National Quality Assurance Standards (NQAS) certification: an impact assessment study in India. Population Research Centre, JSS Institute of Economic Research; PRC Report no. 198, 2020. https:\/\/nhsrcindia.org\/sites\/default\/files\/2021-05\/PRC%20Dharwad_NQAS_Karnataka.pdf. Accessed 14 June 2026."},{"key":"626_CR92","unstructured":"National Health Systems Resource Centre (NHSRC). Standard Treatment Guidelines (STGs) for India. New Delhi: Ministry of Health and Family Welfare, Government of India. https:\/\/qps.nhsrcindia.org\/standard-treatment-guidelines. Accessed 15 June 2026."},{"key":"626_CR93","unstructured":"Centre for Evidence Based Guidelines. Department of Health Research. MoHFW, Government of India. https:\/\/www.dhr.gov.in\/offerings\/schemes-and-services\/details\/centre-for-evidence-based-guidelines-EzN1MTMtQWa. Accessed 9 June 2026."},{"key":"626_CR94","volume-title":"Standard treatment guidelines: a manual for medical therapeutics","author":"S Sharma","year":"2024","unstructured":"Sharma S, Sethi GR. Standard treatment guidelines: a manual for medical therapeutics. 7th ed. Delhi: Wolters Kluwer Health; 2024.","edition":"7th ed"},{"key":"626_CR95","unstructured":"Indian Council of Medical Research. Standard treatment workflows of India. Department of Health Research, Ministry of Health and Family Welfare (2019\u20132022). https:\/\/www.icmr.gov.in\/standard-treatment-workflows-stws. Accessed 14 June 2026."},{"key":"626_CR96","doi-asserted-by":"publisher","first-page":"1178160","DOI":"10.3389\/fpubh.2023.1178160","volume":"11","author":"A Grover","year":"2023","unstructured":"Grover A, Bhargava B, Srivastava S, et al. Developing standard treatment workflows: way to universal healthcare in India. Front Public Health. 2023;11:1178160.","journal-title":"Front Public Health"},{"key":"626_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.659980","volume":"9","author":"F Dureab","year":"2021","unstructured":"Dureab F, Hussain T, Sheikh R, Al-Dheeb N, Al-Awlaqi S, Jain A, et al. Forms of health system fragmentation during conflict: the case of Yemen. Front Public Health. 2021;9:659980. https:\/\/doi.org\/10.3389\/fpubh.2021.659980.","journal-title":"Front Public Health"},{"issue":"3","key":"626_CR98","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4103\/ijcm.ijcm_665_21","volume":"47","author":"C Lahariya","year":"2022","unstructured":"Lahariya C, Sharma S, Agnani M, de Graeve H, Srivastava JN, Bekedam H. Attributes of standard treatment guidelines in clinical settings, and public health facilities in India. Indian J Community Med. 2022;47(3):336\u201342. https:\/\/doi.org\/10.4103\/ijcm.ijcm_665_21.","journal-title":"Indian J Community Med"},{"issue":"1","key":"626_CR99","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/2224-3151.206626","volume":"4","author":"S Sharma","year":"2015","unstructured":"Sharma S, Sethi GR, Gupta U, Chaudhury RR. Barriers and facilitators to development of standard treatment guidelines in India. WHO Southeast Asia J Public Health. 2015;4(1):86\u201391. https:\/\/doi.org\/10.4103\/2224-3151.206626.","journal-title":"WHO Southeast Asia J Public Health"},{"key":"626_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s44250-025-00231-9","volume":"4","author":"S Sharma","year":"2025","unstructured":"Sharma S, Gupta R, Tripathi CB, Bhalla S. Closing the quality gap from awareness to adoption of standard treatment guidelines in clinical practice in India. Discov Health Syst. 2025;4:54. https:\/\/doi.org\/10.1007\/s44250-025-00231-9.","journal-title":"Discov Health Syst"},{"issue":"1","key":"626_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13670-0","volume":"25","author":"S Sharma","year":"2025","unstructured":"Sharma S, Tripathi CB, Annapoorna KN, Dhond SS, Sharma D, Srivastava JN, et al. Bridging the gap between evidence and practice: a national level initiative to implement Standard Treatment Guidelines (STGs) in clinical practice. BMC Health Serv Res. 2025;25(1):1522. https:\/\/doi.org\/10.1186\/s12913-025-13670-0.","journal-title":"BMC Health Serv Res"},{"key":"626_CR102","doi-asserted-by":"publisher","unstructured":"Shubhodip Mitra, Somu G, Mundkur S, et al. Enhancing medication safety through quality accreditation: a study on the impact of NABH initiatives in a tertiary care hospital in South India, 13 August 2025, preprint (Version 1) available at Research Square. https:\/\/doi.org\/10.21203\/rs.3.rs-7312366\/v1. Accessed 13 June 2026.","DOI":"10.21203\/rs.3.rs-7312366\/v1"},{"issue":"1","key":"626_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07097-6","volume":"21","author":"M Hussein","year":"2021","unstructured":"Hussein M, Pavlova M, Ghalwash M, Groot W. The impact of hospital accreditation on the quality of healthcare: a systematic literature review. BMC Health Serv Res. 2021;21(1):1057. https:\/\/doi.org\/10.1186\/s12913-021-07097-6.","journal-title":"BMC Health Serv Res"},{"key":"626_CR104","unstructured":"Pharmaceutical Services Programme, Ministry of Health Malaysia. 2022. https:\/\/pharmacy.moh.gov.my\/en\/documents\/medication-error-me-reporting.html. Accessed 9 June 2026."},{"issue":"9","key":"626_CR105","doi-asserted-by":"publisher","first-page":"799","DOI":"10.5005\/jp-journals-10071-23556","volume":"24","author":"KG Zirpe","year":"2020","unstructured":"Zirpe KG, Seta B, Gholap S, Aurangabadi K, Gurav SK, Deshmukh AM, et al. Incidence of medication error in critical care unit of a tertiary care hospital: where do we stand? Indian J Crit Care Med. 2020;24(9):799\u2013803. https:\/\/doi.org\/10.5005\/jp-journals-10071-23556.","journal-title":"Indian J Crit Care Med."},{"issue":"8","key":"626_CR106","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.20959\/wjpps20208-16805","volume":"9","author":"K Baraiya","year":"2020","unstructured":"Baraiya K, Thummar K. Medication error: a systematic review and comparison of reporting system in USA, UK and India. World J Pharm Pharm Sci. 2020;9(8):1011\u201330. https:\/\/doi.org\/10.20959\/wjpps20208-16805.","journal-title":"World J Pharm Pharm Sci."},{"issue":"2","key":"626_CR107","first-page":"184","volume":"2","author":"P Agrawal","year":"2012","unstructured":"Agrawal P, Sachanb A, Singla RK, Jaina P. Analysis of distribution & risk factors associated with medication errors in Delhi, India. Indo Glob J Pharm Sci. 2012;2(2):184\u201390.","journal-title":"Indo Glob J Pharm Sci."},{"issue":"2","key":"626_CR108","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.imed.2025.01.002","volume":"6","author":"K Zhang","year":"2026","unstructured":"Zhang K, Chen Y, Wang P, He Y, Du Y, Liang H, et al. Impact of telemedicine on chronic disease patients: an overview of systematic reviews. Intell Med. 2026;6(2):226\u201333.","journal-title":"Intell Med"},{"key":"626_CR109","unstructured":"Ministry of Health & Family Welfare (MoHFW). Annual report: health management information system and drug-vaccine management system (2024\u20132025). Government of India. https:\/\/www.mohfw-dohfw.gov.in\/static\/uploads\/2025\/09\/45b06af4508a53a059c74efc930d955e.pdf. Accessed 15 June 2026."},{"issue":"4","key":"626_CR110","doi-asserted-by":"publisher","first-page":"e2100632","DOI":"10.9745\/GHSP-D-21-00632","volume":"10","author":"A Meghani","year":"2022","unstructured":"Meghani A, Tripathi AB, Bilal H, et al. Optimizing the health management information system in Uttar Pradesh, India: implementation insights and key learnings. Glob Health Sci Pract. 2022;10(4):e2100632. https:\/\/doi.org\/10.9745\/GHSP-D-21-00632.","journal-title":"Glob Health Sci Pract"},{"key":"626_CR111","unstructured":"Centers for Disease Control and Prevention (CDC). Laboratory medicine best practices: Barcoding for patient identification. 2023. https:\/\/www.cdc.gov\/labbestpractices\/pdfs\/CDC_BarCodingSummary.pdf. Accessed 15 June 2026."},{"issue":"2","key":"626_CR112","first-page":"45","volume":"30","author":"C Tiu","year":"2025","unstructured":"Tiu C, Isulat T, Ballarta PJ, et al. Barcode Medication Administration and patient safety: an integrative review. Can J Nurs Inform. 2025;30(2):45\u201358.","journal-title":"Can J Nurs Inform."},{"issue":"1","key":"626_CR113","doi-asserted-by":"publisher","DOI":"10.2196\/medinform.7170","volume":"6","author":"D Carli","year":"2018","unstructured":"Carli D, Fahrni G, Bonnabry P, Lovis C. Quality of decision support in computerized provider order entry: systematic literature review. JMIR Med Inform. 2018;6(1):e3. https:\/\/doi.org\/10.2196\/medinform.7170.","journal-title":"JMIR Med Inform"},{"key":"626_CR114","unstructured":"Leapfrog Group. Computerized physician order entry (CPOE) fact sheet: medication safety. Washington, DC: The Leapfrog Group; 2023. https:\/\/ratings.leapfroggroup.org\/sites\/default\/files\/inline-files\/2023%20CPOE%20Fact%20Sheet.pdf. Accessed 13 June 2026."},{"key":"626_CR115","doi-asserted-by":"publisher","unstructured":"Jungreithmayr V,\u00a0Meid AD,\u00a0Implementation Team,\u00a0Haefeli WE,\u00a0Seidling HM. Impact of CPOE implementation on prescription quality in an Indian hospital. BMC Med Inform Decis Mak. 2021;21:279 https:\/\/doi.org\/10.1186\/s12911-021-01607-6.","DOI":"10.1186\/s12911-021-01607-6"},{"key":"626_CR116","unstructured":"World Health Organization. Medication error: key facts about medication errors in the WHO European Region. 2020. https:\/\/cdn.who.int\/media\/docs\/librariesprovider2\/country-sites\/medication-error-wpsd-final.pdf. Accessed 13 June 2026."},{"key":"626_CR117","unstructured":"Joint Commission. National Patient Safety Goal #14: effectively managing medications. 2023. https:\/\/www.jointcommission.org\/en-us\/standards\/national-performance-goals\/effectively-managing-medications. Accessed 13 June 2026."},{"key":"626_CR118","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Medications at transitions and clinical handoffs (MATCH) toolkit (contract no. U18 HS015886). AHRQ. 2023. https:\/\/www.ahrq.gov\/patient-safety\/settings\/hospital\/match\/index.html. Accessed 13 June 2026."},{"key":"626_CR119","unstructured":"Williams LC& Associates. AAAHC medication reconciliation benchmarking study. AAAHC. 12 Dec 2019. https:\/\/www.aaahc.org\/uploads\/2019\/12\/Medication-Reconciliation-Benchmark-StudyFINAL.pdf. Accessed 10 June 2026."},{"key":"626_CR120","unstructured":"National Health Systems Resource Centre. Prescription audit guidelines. Ministry of Health and Family Welfare, Government of India; 2021. https:\/\/nhsrcindia.org\/sites\/default\/files\/2021-07\/1534_Prescription%20Audit%20Guidelines16042021.pdf. Accessed 9 June 2026."},{"issue":"Suppl._2","key":"626_CR121","doi-asserted-by":"publisher","first-page":"ii28","DOI":"10.1093\/ijpp\/riac089.032","volume":"30","author":"K Lai","year":"2022","unstructured":"Lai K, Puaar S. Prevalence and potential clinical significance of near miss dispensing errors at a large teaching hospital in the United Kingdom (UK). Int J Pharm Pract. 2022;30(Suppl._2):ii28. https:\/\/doi.org\/10.1093\/ijpp\/riac089.032.","journal-title":"Int J Pharm Pract"},{"key":"626_CR122","unstructured":"American Society of Health-System Pharmacists. Medication use benchmarking toolkit: suggested metrics and process. ASHP. 2024. https:\/\/www.ashp.org\/-\/media\/assets\/pharmacy-practice\/resource-centers\/practice-management\/ASHP-SICP-Medication-Use-Benchmarking-Toolkit.pdf. Accessed 9 June 2026."},{"key":"626_CR123","unstructured":"Agency for Healthcare Research and Quality. Implementing near-miss reporting and improvement tracking in primary care practices. Advances in patient safety. 2022. https:\/\/www.ahrq.gov\/patient-safety\/reports\/liability\/crane.html. Accessed 10 June 2026."},{"key":"626_CR124","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2025-003345","volume":"14","author":"L Joseph","year":"2025","unstructured":"Joseph L, Deshmukh R, Murugesan M, Nair NA, Antony E, Ramasubramani P, et al. Development of validated, context-specific patient-reported experience measures (PREMs) tools to enhance quality and patient safety in India. BMJ Open Qual. 2025;14:e003345. https:\/\/doi.org\/10.1136\/bmjoq-2025-003345.","journal-title":"BMJ Open Qual"},{"issue":"3","key":"626_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0319645","volume":"20","author":"R Rohilla","year":"2025","unstructured":"Rohilla R, Gupta M, Anish TS, Cherian JJ, Singh MP, Kakkar AK, et al. Impact of multi-pronged intervention on reducing surgical site infections (IMPRESS study): protocol for multicentre implementation research. PLoS ONE. 2025;20(3):e0319645. https:\/\/doi.org\/10.1371\/journal.pone.0319645.","journal-title":"PLoS ONE"},{"key":"626_CR126","doi-asserted-by":"crossref","unstructured":"Yadav AK. Review on patient safety in the healthcare sector in India. Int J Future Med Res. 2025;7(4). https:\/\/www.ijfmr.com\/papers\/2025\/4\/54570.pdf. Accessed 13 June 2026.","DOI":"10.36948\/ijfmr.2025.v07i04.54570"},{"key":"626_CR127","unstructured":"World Health Organization. Global patient safety report 2024: a first global review of national-level implementation of the Global Patient Safety Action Plan 2021\u20132030. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240095458. Accessed 10 June 2026."},{"key":"626_CR128","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Patient safety research summaries 2023\u20132024. 2024. https:\/\/psnet.ahrq.gov\/issue\/patient-safety-research-summaries. Accessed 10 June 2026."},{"key":"626_CR129","unstructured":"World Health Organization. Evidence synthesis for health policy and systems: a methods guide. Langlois EV, Daniels K, Akl EA, editors. 2018. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/400b87ce-29ce-41cb-b37f-ee701e17d6a6\/content. Accessed 14 June 2026."},{"key":"626_CR130","volume-title":"Strengthening national capacities in evidence-based decision-making for the uptake and impact of norms and standards","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Strengthening national capacities in evidence-based decision-making for the uptake and impact of norms and standards. Geneva: WHO; 2025."},{"issue":"2","key":"626_CR131","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/08404704211063584","volume":"35","author":"E McLaney","year":"2022","unstructured":"McLaney E, Morassaei S, Hughes L, Davies R, Campbell M, Di Prospero L. A framework for interprofessional team collaboration in a hospital setting: advancing team competencies and behaviours. Healthc Manage Forum. 2022;35(2):112\u20137.","journal-title":"Healthc Manage Forum"},{"issue":"2","key":"626_CR132","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3126\/nje.v13i2.58243","volume":"13","author":"B Sathian","year":"2023","unstructured":"Sathian B, van Teijlingen E, Simkhada P, et al. Strengthening healthcare through academic and industry partnership research. Nepal J Epidemiol. 2023;13(2):1264\u20137.","journal-title":"Nepal J Epidemiol."},{"issue":"1","key":"626_CR133","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5334\/aogh.3948","volume":"89","author":"PH Kilmarx","year":"2023","unstructured":"Kilmarx PH, Maitin T, Adam T, et al. Increasing effectiveness and equity in strengthening health research capacity using data and metrics: recent advances of the ESSENCE mechanism. Ann Glob Health. 2023;89(1):38.","journal-title":"Ann Glob Health"},{"issue":"40","key":"626_CR134","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1093\/eurheartj\/ehad279","volume":"44","author":"F Zannad","year":"2023","unstructured":"Zannad F, Crea F, Keaney J, et al. Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges. Eur Heart J. 2023;44(40):4220\u20139.","journal-title":"Eur Heart J"},{"key":"626_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004569","volume":"22","author":"M Bagita-Vangana","year":"2025","unstructured":"Bagita-Vangana M, Unger HW, Thriemer K. Dissemination of research results to participants: a systematic review. PLoS Med. 2025;22:e1004569.","journal-title":"PLoS Med"},{"key":"626_CR136","volume-title":"Effective research capacity strengthening: a quick guide for funders","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Effective research capacity strengthening: a quick guide for funders. Geneva: WHO\/TDR; 2023."},{"key":"626_CR137","unstructured":"National Institutes of Health. Guide to training and mentoring in the intramural research program. Bethesda, MD: NIH; updated guidance. https:\/\/oir.nih.gov\/sourcebook\/mentoring-training\/guide-training-mentoring. Accessed 14 June 2026."},{"key":"626_CR138","unstructured":"American College of Healthcare Executives and Institute for Healthcare Improvement\/NPSF Lucian Leape Institute. Leading a culture of safety: a blueprint for success. 2017. https:\/\/www.scribd.com\/document\/389715390\/leading-a-culture-of-safety-a-blueprint-for-success. Accessed 10 June 2026."},{"key":"626_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-10828-0","volume":"24","author":"A Endalamaw","year":"2024","unstructured":"Endalamaw A, Khatri RB, Mengistu TS, et al. A scoping review of continuous quality improvement in healthcare system: conceptualization, models and tools, barriers and facilitators, and impact. BMC Health Serv Res. 2024;24:487. https:\/\/doi.org\/10.1186\/s12913-024-10828-0.","journal-title":"BMC Health Serv Res"},{"key":"626_CR140","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2023-002506","volume":"13","author":"M Finn","year":"2024","unstructured":"Finn M, Walsh A, Rafter N, et al. Effect of interventions to improve safety culture on healthcare workers in hospital settings: a systematic review of the international literature. BMJ Open Qual. 2024;13:e002506. https:\/\/doi.org\/10.1136\/bmjoq-2023-002506.","journal-title":"BMJ Open Qual"},{"key":"626_CR141","doi-asserted-by":"publisher","unstructured":"Guntschnig S, Barbosa R, Jenzer H, et al. Tackling medication errors: how a systems approach improves patient safety. Eur J Hosp Pharm. 2025;0:1-7.\u00a0https:\/\/doi.org\/10.1136\/ejhpharm-2025-004533. Accessed 25 Jul 2026.","DOI":"10.1136\/ejhpharm-2025-004533"},{"key":"626_CR142","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/bmjqs-2019-010581","volume":"29","author":"AL Neves","year":"2020","unstructured":"Neves AL, Freise L, Laranjo L, et al. Impact of providing patients access to electronic health records on quality and safety of care: a systematic review and meta-analysis. BMJ Qual Saf. 2020;29:1019\u201332.","journal-title":"BMJ Qual Saf"},{"key":"626_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.870587","volume":"9","author":"CS Webster","year":"2022","unstructured":"Webster CS. Existing knowledge of medication error must be better translated into improved patient safety. Front Med. 2022;9:870587. https:\/\/doi.org\/10.3389\/fmed.2022.870587.","journal-title":"Front Med"},{"key":"626_CR144","unstructured":"World Health Organization. SCORE for health data systems: strengthening RHIS and MIS for service delivery. 2025. https:\/\/cdn.who.int\/media\/docs\/default-source\/world-health-data-platform\/score\/who_2021-01-27_global-report-score_tb_v3.pdf. Accessed 9 June 2026."},{"key":"626_CR145","doi-asserted-by":"publisher","DOI":"10.33546\/bnj.3548","author":"BA Pramesona","year":"2025","unstructured":"Pramesona BA, Wardani D. Proportion of medication error reporting and its associated factors among healthcare workers in Indonesia: a mixed-methods study. Belitung Nurs J. 2025. https:\/\/doi.org\/10.33546\/bnj.3548.","journal-title":"Belitung Nurs J"},{"key":"626_CR146","unstructured":"Joint Commission. Sentinel event data annual report (2024). https:\/\/digitalassets.jointcommission.org\/api\/public\/content\/eac7511986c0442a9c1ae04b1aa02cc0?v=ad34daa0. Accessed 13 June 2026."},{"key":"626_CR147","unstructured":"World Health Organization. Regional Office for South-East Asia. Decade for health workforce strengthening in SEAR 2015-2024, mid-term review. 2020.\u00a0https:\/\/www.who.int\/publications\/i\/item\/9789290227779. Accessed 10 June 2026."},{"key":"626_CR148","unstructured":"Zapata T. Implementing a decade of strengthening the health workforce in the WHO South-East Asia Region: achievements and way forward for primary health care. 2022. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/bb4ad5ba-fe3c-4168-9310-1b81013ad613\/content. Accessed 9 June 2026."},{"key":"626_CR149","unstructured":"WHO SEARO. Regional strategic roadmap for health workforce and patient safety. 2024. https:\/\/www.who.int\/southeastasia\/health-topics\/health-workforce. Accessed 13 June 2026."},{"key":"626_CR150","doi-asserted-by":"publisher","unstructured":"World Health Organization. Health workforce governance in South-East Asia: analysis and recommendations. 2019. https:\/\/doi.org\/10.1186\/s12960-019-0385-1.pdf. Accessed 15 June 2026.","DOI":"10.1186\/s12960-019-0385-1.pdf"},{"key":"626_CR151","doi-asserted-by":"crossref","unstructured":"Saravanos G. Immunisation health workforce capacity building in Southeast Asia: reflections from training programme implementation in Cambodia and Lao PDR, 2025. https:\/\/gh.bmj.com\/content\/10\/2\/e018007. Accessed 9 June 2026.","DOI":"10.1136\/bmjgh-2024-018007"},{"key":"626_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s12960-019-0385-1","volume":"17","author":"G Cometto","year":"2019","unstructured":"Cometto G, Nartey E, Zapata T, et al. Analysing public sector institutional capacity for health workforce governance in the South-East Asia region of WHO. Hum Resour Health. 2019;17:43. https:\/\/doi.org\/10.1186\/s12960-019-0385-1.","journal-title":"Hum Resour Health"},{"key":"626_CR153","unstructured":"ASEAN. ASCC research and development policy brief: digital literacy and transformation. 2025. https:\/\/asean.org\/wp-content\/uploads\/2025\/05\/ASCC-RD_Policy-Brief_FoE-19_2025_Digital-Literacy-and-Transformation.pdf. Accessed 9 June 2026."},{"key":"626_CR154","unstructured":"Livia Feliciani Nazara. Integrating digital skills in ASEAN education to boost digital literacy. 2024. https:\/\/www.eria.org\/news-and-views\/integrating-digital-skills-in-asean-education-to-boost-digital-literacy. Accessed 9 June 2026."},{"issue":"4","key":"626_CR155","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1542\/hpeds.2023-007396","volume":"14","author":"SM Gunkelman","year":"2024","unstructured":"Gunkelman SM, Jamerino-Thrush J, Genet K, Blackford M, Jones K, Bigham MT. Improving accuracy of medication reconciliation for hospitalized children: a quality project. Hosp Pediatr. 2024;14(4):300\u20137. https:\/\/doi.org\/10.1542\/hpeds.2023-007396.","journal-title":"Hosp Pediatr"},{"issue":"6","key":"626_CR156","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3949\/ccjm.87a.19102","volume":"87","author":"EB Neal","year":"2020","unstructured":"Neal EB, Sponsler K. Medication reconciliation in the hospital and postdischarge: best practices and evidence-based strategies. Cleveland Clin J Med. 2020;87(6):351\u201360. https:\/\/doi.org\/10.3949\/ccjm.87a.19102.","journal-title":"Cleveland Clin J Med."},{"key":"626_CR157","doi-asserted-by":"publisher","unstructured":"Killin A, et al. Advanced medication reconciliation: Impact of electronic systems on reducing discrepancies during transitions of care. J Patient Saf. 2021;17(4):290\u20138. https:\/\/doi.org\/10.1097\/PTS.0000000000000857. Accessed 13 June 2026.","DOI":"10.1097\/PTS.0000000000000857"},{"key":"626_CR158","unstructured":"European Medicines Agency. Legal framework: pharmacovigilance. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/pharmacovigilance-overview\/legal-framework-pharmacovigilance. Accessed 15 June 2026."},{"key":"626_CR159","unstructured":"European Union. Regulation (EU) No 1235\/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726\/2004. EUR-Lex. https:\/\/eur-lex.europa.eu\/eli\/reg\/2010\/1235\/oj\/eng. Accessed 15 June 2026."},{"key":"626_CR160","unstructured":"US Food and Drug Administration. Drug Supply Chain Security Act (DSCSA). https:\/\/www.fda.gov\/drugs\/drug-supply-chain-integrity\/drug-supply-chain-security-act-dscsa. Accessed 15 June 2026."},{"key":"626_CR161","unstructured":"African Union. Treaty for the Establishment of the African Medicines Agency. African Union. https:\/\/au.int\/sites\/default\/files\/treaties\/36892-treaty-0069_-_ama_treaty_e.pdf. Accessed 15 June 2026."},{"key":"626_CR162","unstructured":"AUDA-NEPAD. African Medicines Regulatory Harmonization (AMRH). https:\/\/www.nepad.org\/programme-details\/998. Accessed 15 June 2026."}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-026-00626-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-026-00626-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-026-00626-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:23:07Z","timestamp":1788495787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-026-00626-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":162,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1007\/s40290-026-00626-w","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"7 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sangeeta Sharma, Parminder Gautam, Deepika Sharma, J.N. Srivastava, and Atul Kotwal have no conflicts of interest that are directly relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data sharing is not applicable to this article as no datasets were generated for this article.","order":5,"name":"Ethics","label":"Availability of data and material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SS contributed to the study conception, design, material preparation, and manuscript writing. The first draft of the manuscript was written by SS, and all authors commented on previous versions of the manuscript. SS edited the final manuscript. All authors read and approved the final manuscript.","order":7,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}